BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2016910)

  • 1. Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Lymphoma Study Group (1984-1987).
    Leuk Res; 1991; 15(2-3):81-90. PubMed ID: 2016910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).
    Shimoyama M
    Br J Haematol; 1991 Nov; 79(3):428-37. PubMed ID: 1751370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic index for acute- and lymphoma-type adult T-cell leukemia/lymphoma.
    Katsuya H; Yamanaka T; Ishitsuka K; Utsunomiya A; Sasaki H; Hanada S; Eto T; Moriuchi Y; Saburi Y; Miyahara M; Sueoka E; Uike N; Yoshida S; Yamashita K; Tsukasaki K; Suzushima H; Ohno Y; Matsuoka H; Jo T; Suzumiya J; Tamura K
    J Clin Oncol; 2012 May; 30(14):1635-40. PubMed ID: 22473153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term study of indolent adult T-cell leukemia-lymphoma.
    Takasaki Y; Iwanaga M; Imaizumi Y; Tawara M; Joh T; Kohno T; Yamada Y; Kamihira S; Ikeda S; Miyazaki Y; Tomonaga M; Tsukasaki K
    Blood; 2010 Jun; 115(22):4337-43. PubMed ID: 20348391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in prognostic factors between leukemia and lymphoma type of adult T-cell leukemia.
    Shimamoto Y; Ono K; Sano M; Matsuzaki M; Suga K; Sueoka E; Tokioka T; Yamaguchi M; Suzuki H; Sato H
    Cancer; 1989 Jan; 63(2):289-94. PubMed ID: 2910433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T-cell leukemia virus type I Tax genotype analysis in Okinawa, the southernmost and remotest islands of Japan: Different distributions compared with mainland Japan and the potential value for the prognosis of aggressive adult T-cell leukemia/lymphoma.
    Sakihama S; Saito M; Kuba-Miyara M; Tomoyose T; Taira N; Miyagi T; Hayashi M; Kinjo S; Nakachi S; Tedokon I; Nishi Y; Tamaki K; Morichika K; Uchihara JN; Morishima S; Karube KN; Tanaka Y; Masuzaki H; Fukushima T
    Leuk Res; 2017 Oct; 61():18-24. PubMed ID: 28866351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult T-cell leukemia/lymphoma in Bahia, Brazil: analysis of prognostic factors in a group of 70 patients.
    Bittencourt AL; da Graças Vieira M; Brites CR; Farre L; Barbosa HS
    Am J Clin Pathol; 2007 Nov; 128(5):875-82. PubMed ID: 17951212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: clinical, histological and immunohistochemical features of 52 cases.
    Bittencourt AL; Barbosa HS; Vieira MD; Farré L
    Acta Oncol; 2009; 48(4):598-604. PubMed ID: 19165640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A).
    Fukushima T; Nomura S; Shimoyama M; Shibata T; Imaizumi Y; Moriuchi Y; Tomoyose T; Uozumi K; Kobayashi Y; Fukushima N; Utsunomiya A; Tara M; Nosaka K; Hidaka M; Uike N; Yoshida S; Tamura K; Ishitsuka K; Kurosawa M; Nakata M; Fukuda H; Hotta T; Tobinai K; Tsukasaki K
    Br J Haematol; 2014 Sep; 166(5):739-48. PubMed ID: 24931507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
    Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.
    Bazarbachi A; Plumelle Y; Carlos Ramos J; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington W; Panelatti G; Hermine O
    J Clin Oncol; 2010 Sep; 28(27):4177-83. PubMed ID: 20585095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia.
    Kamihira S; Atogami S; Sohda H; Momita S; Yamada Y; Tomonaga M
    Cancer; 1994 Jun; 73(11):2753-8. PubMed ID: 8194016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical factors to predict outcome following mogamulizumab in adult T-cell leukemia-lymphoma.
    Nakashima J; Imaizumi Y; Taniguchi H; Ando K; Iwanaga M; Itonaga H; Sato S; Sawayama Y; Hata T; Yoshida S; Moriuchi Y; Miyazaki Y
    Int J Hematol; 2018 Nov; 108(5):516-523. PubMed ID: 30032392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult T-cell leukemia/lymphoma in Jamaica and its relationship to human T-cell leukemia/lymphoma virus type I-associated lymphoproliferative disease.
    Gibbs WN; Lofters WS; Campbell M; Hanchard B; LaGrenade L; Clark J; Cranston B; Saxinger C; Gallo R; Blattner WA
    Princess Takamatsu Symp; 1984; 15():77-90. PubMed ID: 6100652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia.
    Kubuki Y; Suzuki M; Sasaki H; Toyama T; Yamashita K; Maeda K; Ido A; Matsuoka H; Okayama A; Nakanishi T; Tsubouchi H
    Leuk Lymphoma; 2005 Mar; 46(3):393-9. PubMed ID: 15621829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term maintenance combination chemotherapy with OPEC/MPEC (vincristine or methotrexate, prednisolone, etoposide and cyclophosphamide) or with daily oral etoposide and prednisolone can improve survival and quality of life in adult T-cell leukemia/lymphoma.
    Matsushita K; Matsumoto T; Ohtsubo H; Fujiwara H; Imamura N; Hidaka S; Kukita T; Tei C; Matsumoto M; Arima N
    Leuk Lymphoma; 1999 Dec; 36(1-2):67-75. PubMed ID: 10613451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma.
    Beltran B; Quiñones P; Morales D; Cotrina E; Castillo JJ
    Leuk Res; 2011 Mar; 35(3):334-9. PubMed ID: 20828817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation.
    Fuji S; Yamaguchi T; Inoue Y; Utsunomiya A; Moriuchi Y; Uchimaru K; Owatari S; Miyagi T; Taguchi J; Choi I; Otsuka E; Nakachi S; Yamamoto H; Kurosawa S; Tobinai K; Fukuda T
    Haematologica; 2017 Jul; 102(7):1258-1265. PubMed ID: 28341734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of Clinical Characteristics and Prognostic Factors of 223 Newly Diagnosed Hodgkin's Lymphoma Patients].
    Liu S; Ma J; Yue YF; Li Q; Yang HL; Yu Y; Wang XF; Zhao ZG; Zhang YZ; Wang YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1296-300. PubMed ID: 26524026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum deoxythymidine kinase in adult T-cell leukemia-lymphoma and its related disorders.
    Sadamori N; Ikeda S; Yamaguchi K; Mine M; Hakariya S; Kinoshita H; Hayashi K; Nakamura T; Nagataki S; Ichimaru M
    Leuk Res; 1991; 15(2-3):99-103. PubMed ID: 2016911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.